Literature DB >> 19728088

The Gini concentration test for survival data.

Marco Bonetti1, Chiara Gigliarano, Pietro Muliere.   

Abstract

We apply the well known Gini index to the measurement of concentration in survival times within groups of patients, and as a way to compare the distribution of survival times across groups of patients in clinical studies. In particular, we propose an estimator of a restricted version of the index from right censored data. We derive the asymptotic distribution of the resulting Gini statistic, and construct an estimator for its asymptotic variance. We use these results to propose a novel test for differences in the heterogeneity of survival distributions, which may suggest the presence of a differential treatment effect for some groups of patients. We focus in particular on traditional and generalized cure rate models, i.e., mixture models with a distribution of the lifetimes of the cured patients that is either degenerate at infinity or has a density. Results from a simulation study suggest that the Gini index is useful in some situations, and that it should be considered together with existing tests (in particular, the Log-rank, Wilcoxon, and Gray-Tsiatis tests). Use of the test is illustrated on the classic data arising from the Eastern Cooperative Oncology Group melanoma clinical trial E1690.

Entities:  

Mesh:

Year:  2009        PMID: 19728088     DOI: 10.1007/s10985-009-9125-5

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  8 in total

1.  A comparison of tests of the difference in the proportion of patients who are cured.

Authors:  R Sposto; H N Sather; S A Baker
Journal:  Biometrics       Date:  1992-03       Impact factor: 2.571

2.  A general class of Bayesian survival models with zero and nonzero cure fractions.

Authors:  Guosheng Yin; Joseph G Ibrahim
Journal:  Biometrics       Date:  2005-06       Impact factor: 2.571

3.  Statistics in medicine--reporting of subgroup analyses in clinical trials.

Authors:  Rui Wang; Stephen W Lagakos; James H Ware; David J Hunter; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

4.  Nonparametric estimation and testing in a cure model.

Authors:  E M Laska; M J Meisner
Journal:  Biometrics       Date:  1992-12       Impact factor: 2.571

5.  The large sample distribution of the weighted log rank statistic under general local alternatives.

Authors:  M Ewell; J G Ibrahim
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

6.  A linear rank test for use when the main interest is in differences in cure rates.

Authors:  R J Gray; A A Tsiatis
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

7.  Cure rate models: power of the logrank and generalized Wilcoxon tests.

Authors:  J Halpern; B W Brown
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

8.  High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Authors:  J M Kirkwood; J G Ibrahim; V K Sondak; J Richards; L E Flaherty; M S Ernstoff; T J Smith; U Rao; M Steele; R H Blum
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

  8 in total
  5 in total

1.  Gini index estimation for lifetime data.

Authors:  Xiaofeng Lv; Gupeng Zhang; Guangyu Ren
Journal:  Lifetime Data Anal       Date:  2016-01-25       Impact factor: 1.588

2.  Longevity and concentration in survival times: the log-scale-location family of failure time models.

Authors:  Chiara Gigliarano; Ugofilippo Basellini; Marco Bonetti
Journal:  Lifetime Data Anal       Date:  2016-02-01       Impact factor: 1.588

3.  Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer.

Authors:  Vincent Vinh-Hung; Hilde Van Parijs; Olena Gorobets; Christel Fontaine; Nam P Nguyen; Bhumsuk Keam; Dung Minh Nguyen; Mark De Ridder
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

4.  The assessment of inequality on geographical distribution of non-cardiac intensive care beds in iran.

Authors:  A Ameryoun; M Meskarpour-Amiri; M Lorgard Dezfuli-Nejad; Hr Khoddami-Vishteh; Sh Tofighi
Journal:  Iran J Public Health       Date:  2011-06-30       Impact factor: 1.429

5.  Dynamics of life expectancy and life span equality.

Authors:  José Manuel Aburto; Francisco Villavicencio; Ugofilippo Basellini; Søren Kjærgaard; James W Vaupel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.